Bacillus cereus: Difference between revisions

Jump to navigation Jump to search
Line 53: Line 53:
==Antimicrobial therapy==
==Antimicrobial therapy==


:* (1) Food poisoning: Bacillus cereus with two forms.(a) Emetic phase: 1-6 hrs after ingestion contaminated usually starchy food, e.g., fried rice. (b) Diarrheal phase: 10-12 hrs after eating e.g. tainted meats, milk, vegetables, etc. with watery diarrhea, tenesmus lasting <2-10 days.
*Bacillus cereus {{cite book | last = Bartlett | first = John | title = Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases | publisher = Jones and Bartlett Learning | location = Burlington, MA | year = 2012 | isbn = 978-1449625580 }}
:: Note: Food poisoning is self-limited, no antibiotics necessary. Treatment is Supportive therapy, hydration, and anti-emetics. Prevention is by fried/boiled rice should be maintained >60° C or rapidly cooled <8 ° C to avoid room temperature germination of spores and toxin.


:* (2) Bacteremia:
:* (1) Food poisoning
::* Preferred treatment: Food poisoning is self-limited, no antibiotics necessary. Treatment is Supportive therapy, hydration, and anti-emetics. Prevention is by fried/boiled rice should be maintained >60° C or rapidly cooled <8 ° C to avoid room temperature germination of spores and toxin.
:: Note (1): Bacillus cereus with two forms.(a) Emetic phase: 1-6 hrs after ingestion contaminated usually starchy food, e.g., fried rice. (b) Diarrheal phase: 10-12 hrs after eating e.g. tainted meats, milk, vegetables, etc. with watery diarrhea, tenesmus lasting <2-10 days.
 
:* (2) Bacteremia  
::* Preferred regimen:  [[Vancomycin]] 15 mg/kg IV q12h.
::* Preferred regimen:  [[Vancomycin]] 15 mg/kg IV q12h.
::* Alternative regimen: [[Clindamycin]] 600 mg IV q8h
::* Alternative regimen: [[Clindamycin]] 600 mg IV q8h
Line 63: Line 66:
::: Note (3): Source of pseudobacteremia is contaminated blood cultures, gloves, syringes, etc. Often transient bacteremia of no significance in intravenous drug user population.
::: Note (3): Source of pseudobacteremia is contaminated blood cultures, gloves, syringes, etc. Often transient bacteremia of no significance in intravenous drug user population.


:* (3) Meningitis, brain abscess:
:* (3) Meningitis, brain abscess
::* Preferred regimen: [[Vancomycin]] 15 mg/kg IV q12h.
::* Preferred regimen: [[Vancomycin]] 15 mg/kg IV q12h.
::* Alternative regimen: [[Clindamycin]] 600 mg IV q8h.
::* Alternative regimen: [[Clindamycin]] 600 mg IV q8h.
Line 69: Line 72:
::: Note(2):  Uncommon presentations, may complicate otitis, mastoiditis, neurosurgical procedures, and shunts.
::: Note(2):  Uncommon presentations, may complicate otitis, mastoiditis, neurosurgical procedures, and shunts.


:* (4) Endophthalmitis:
:* (4) Endophthalmitis
::* Preferred regimen: [[Clindamycin]] 450 mcg intravitreal {{and}} [[Gentamicin]] 400 mcg intravitreal {{or}} [[Dexamethasone]] intravitreal {{and}} [[Vancomycin]] 15 mg/kg IV q12h.
::* Preferred regimen: [[Clindamycin]] 450 mcg intravitreal {{and}} [[Gentamicin]] 400 mcg intravitreal {{or}} [[Dexamethasone]] intravitreal {{and}} [[Vancomycin]] 15 mg/kg IV q12h.
::* Alternative regimen: [[Clindamycin]] 600 mg IV q8h
::* Alternative regimen: [[Clindamycin]] 600 mg IV q8h
Line 78: Line 81:
::: Note (5): primary pathogen of post-traumatic , risk factor also intravenous drug use. May also cause keratitis, orbital abscess, conjunctivitis, dacryocystitis.
::: Note (5): primary pathogen of post-traumatic , risk factor also intravenous drug use. May also cause keratitis, orbital abscess, conjunctivitis, dacryocystitis.


:* (5) Endocarditis:
:* (5) Endocarditis  
::* Preferred regimen: [[Vancomycin]] 15 mg/kg IV q12h {{or}} [[Clindamycin]] 600 mg IV q8h.
::* Preferred regimen: [[Vancomycin]] 15 mg/kg IV q12h {{or}} [[Clindamycin]] 600 mg IV q8h.
::: Note (1):  Well-described but rare complication seen in intravenous drug user . Most blood cultures in intravenous drug user positive for bacillus are contaminates or represent transient bacteremia.
::: Note (1):  Well-described but rare complication seen in intravenous drug user . Most blood cultures in intravenous drug user positive for bacillus are contaminates or represent transient bacteremia.
Line 84: Line 87:
::: Note (3): Tricuspid valve endocarditis mostly indolent in nature.
::: Note (3): Tricuspid valve endocarditis mostly indolent in nature.


:* (6) Soft tissue:
:* (6) Soft tissue
::* Preferred regimen: [[Vancomycin]] 15 mg/kg IV q12h.
::* Preferred regimen: [[Vancomycin]] 15 mg/kg IV q12h.
::* Alternative regimen: [[Clindamycin]] 600 mg IV q8h.
::* Alternative regimen: [[Clindamycin]] 600 mg IV q8h.
::: note:  rare reports of fasciitis.
::: note:  rare reports of fasciitis.


:* (7) Pneumonia:
:* (7) Pneumonia  
::* Preferred regimen: [[Vancomycin]] 15 mg/kg IV q12h.
::* Preferred regimen: [[Vancomycin]] 15 mg/kg IV q12h.
::* Alternative regimen: [[Clindamycin]] 600 mg IV q8h.
::* Alternative regimen: [[Clindamycin]] 600 mg IV q8h.
::: Note: rare pathogen of compromised host. May mimic Bacillus anthracis-type presentation.
::: Note: rare pathogen of compromised host. May mimic Bacillus anthracis-type presentation.
==References==
{{reflist|2}}


==References==
==References==

Revision as of 13:46, 29 June 2015

Bacillus cereus
B. cereus on sheep blood agar plate.
B. cereus on sheep blood agar plate.
Scientific classification
Kingdom: Bacteria
Phylum: Firmicutes
Class: Bacilli
Order: Bacillales
Family: Bacillaceae
Genus: Bacillus
Species: cereus
Binomial name
Bacillus cereus
Frankland & Frankland 1887

WikiDoc Resources for Bacillus cereus

Articles

Most recent articles on Bacillus cereus

Most cited articles on Bacillus cereus

Review articles on Bacillus cereus

Articles on Bacillus cereus in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bacillus cereus

Images of Bacillus cereus

Photos of Bacillus cereus

Podcasts & MP3s on Bacillus cereus

Videos on Bacillus cereus

Evidence Based Medicine

Cochrane Collaboration on Bacillus cereus

Bandolier on Bacillus cereus

TRIP on Bacillus cereus

Clinical Trials

Ongoing Trials on Bacillus cereus at Clinical Trials.gov

Trial results on Bacillus cereus

Clinical Trials on Bacillus cereus at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bacillus cereus

NICE Guidance on Bacillus cereus

NHS PRODIGY Guidance

FDA on Bacillus cereus

CDC on Bacillus cereus

Books

Books on Bacillus cereus

News

Bacillus cereus in the news

Be alerted to news on Bacillus cereus

News trends on Bacillus cereus

Commentary

Blogs on Bacillus cereus

Definitions

Definitions of Bacillus cereus

Patient Resources / Community

Patient resources on Bacillus cereus

Discussion groups on Bacillus cereus

Patient Handouts on Bacillus cereus

Directions to Hospitals Treating Bacillus cereus

Risk calculators and risk factors for Bacillus cereus

Healthcare Provider Resources

Symptoms of Bacillus cereus

Causes & Risk Factors for Bacillus cereus

Diagnostic studies for Bacillus cereus

Treatment of Bacillus cereus

Continuing Medical Education (CME)

CME Programs on Bacillus cereus

International

Bacillus cereus en Espanol

Bacillus cereus en Francais

Business

Bacillus cereus in the Marketplace

Patents on Bacillus cereus

Experimental / Informatics

List of terms related to Bacillus cereus


Bacillus cereus is an endemic, soil-dwelling, Gram-positive, rod shaped, beta hemolytic bacteria that causes foodborne illness.[1] It is the cause of "Fried Rice Syndrome". B. cereus bacteria are facultative aerobes, and like other members of the genus Bacillus can produce protective endospores.

Pathogenesis

B. cereus is responsible for a minority of foodborne illnesses (2–5%). It is known to create heavy nausea, vomiting, and abdominal periods. [2] Generally speaking, Bacillus foodborne illnesses occur due to survival of the bacterial spores when food is improperly cooked.[3] This problem is compounded when food is then improperly refrigerated, allowing the spores to germinate.[4] Bacterial growth results in production of enterotoxin, and ingestion leads to two types of illness, diarrheal and emetic syndrome.[5]

  • The diarrheal type is associated with a wide-range of foods, has an 8–16 hour incubation time and is associated with diarrhea and gastrointestinal pain. Also know as the long-incubation form of B. cereus food poisoning, it can be difficult to differentiate from poisoning caused by Clostridium perfringens.[6]
  • In the emetic form, cooked rice that is improperly refrigerated is the most common cause, leading to nausea and vomiting 1–5 hours after consumption. This form can be difficult to distinguish from other short-term bacterial foodborne pathogens (e.g. Staphylococcus aureus).[6]

It was previously thought that the timing of the toxin production might be responsible for the two different types, but in fact the emetic syndrome is caused by a toxin called cereulide that is found only in emetic strains and is not part of the 'standard toolbox' of B. cereus. Cereulide a dodecadepsipeptide produced by non-ribosomal peptide synthesis (NRPS), which is somewhat unusual in itself. It was shown independently by two research groups to be encoded on a plasmid, which is called pCERE01 [7] or pBCE4810 [8]. Interestingly, this plasmid shares a common backbone with the virulence plasmid pXO1, which encodes the anthrax toxin genes in B. anthracis, but with a different pathogenicity island. Periodontal isolates of B. cereus also possess distinct pXO1-like plasmids.

Gallery


Treatment

Antimicrobial therapy

  • Bacillus cereus Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.
  • (1) Food poisoning
  • Preferred treatment: Food poisoning is self-limited, no antibiotics necessary. Treatment is Supportive therapy, hydration, and anti-emetics. Prevention is by fried/boiled rice should be maintained >60° C or rapidly cooled <8 ° C to avoid room temperature germination of spores and toxin.
Note (1): Bacillus cereus with two forms.(a) Emetic phase: 1-6 hrs after ingestion contaminated usually starchy food, e.g., fried rice. (b) Diarrheal phase: 10-12 hrs after eating e.g. tainted meats, milk, vegetables, etc. with watery diarrhea, tenesmus lasting <2-10 days.
  • (2) Bacteremia
Note (1): Bacillus cereus often resistant to beta-lactams.
Note (2): Uncommon, may complicate mixed infections including surgical wounds or infected necrotic tumors.
Note (3): Source of pseudobacteremia is contaminated blood cultures, gloves, syringes, etc. Often transient bacteremia of no significance in intravenous drug user population.
  • (3) Meningitis, brain abscess
Note (1): Blood culture isolates are mostly contaminates until proven otherwise, especially in intravenous drug user population.
Note(2): Uncommon presentations, may complicate otitis, mastoiditis, neurosurgical procedures, and shunts.
  • (4) Endophthalmitis
Note (1): Prognosis for sight retention poor.
Note (2): Rapid, massive destruction of vitreous/retina in intravenous drug user or posttraumatic with ringabscess within 48 hrs. Pathognomic Bacillus cereus panophthalmitis.
Note (3): Early ophthalmological consultation, culture ocular fluids. Early vitrectomy and intravitreal antibiotics is advocated.
Note (4): Ocular infections devastating and require quick intervention.
Note (5): primary pathogen of post-traumatic , risk factor also intravenous drug use. May also cause keratitis, orbital abscess, conjunctivitis, dacryocystitis.
  • (5) Endocarditis
Note (1): Well-described but rare complication seen in intravenous drug user . Most blood cultures in intravenous drug user positive for bacillus are contaminates or represent transient bacteremia.
Note (2): Evidence of valvular involvement should be sought by echocardiography to prove endocarditis. Tricuspid valve involvement most common. Course indolent.
Note (3): Tricuspid valve endocarditis mostly indolent in nature.
  • (6) Soft tissue
note: rare reports of fasciitis.
  • (7) Pneumonia
Note: rare pathogen of compromised host. May mimic Bacillus anthracis-type presentation.

References

  1. Ryan KJ; Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. ISBN 0-8385-8529-9.
  2. Kotiranta A, Lounatmaa K, Haapasalo M (2000). "Epidemiology and pathogenesis of Bacillus cereus infections". Microbes Infect. 2 (2): 189–98. PMID 10742691.
  3. Turnbull PCB (1996). Bacillus. In: Baron's Medical Microbiology (Barron S et al, eds.) (4th ed. ed.). Univ of Texas Medical Branch. (via NCBI Bookshelf) ISBN 0-9631172-1-1.
  4. McKillip JL (2000). "Prevalence and expression of enterotoxins in Bacillus cereus and other Bacillus spp., a literature review". Antonie Van Leeuwenhoek. 77 (4): 393–9. PMID 10959569.
  5. Ehling-Schulz M, Fricker M, Scherer S (2004). "Bacillus cereus, the causative agent of an emetic type of food-borne illness". Mol Nutr Food Res. 48 (7): 479–87. PMID 15538709.
  6. 6.0 6.1 "Bacillus cereus". Todar's Online Textbook of Bacteriology. Retrieved 2006-04-10.
  7. Hoton FM, Andrup L, Swiecicka I, Mahillon J (2005). "The cereulide genetic determinants of emetic Bacillus cereus are plasmid-borne". Microbiology. 151 (7): 2121–4. PMID 16000702.
  8. Ehling-Schulz M, Fricker M, Grallert H, Rieck P, Wagner M, Scherer S (2006). "Cereulide synthetase gene cluster from emetic Bacillus cereus: structure and location on a mega virulence plasmid related to Bacillus anthracis toxin plasmid pXO1". BMC Microbiol. 6 (20). PMID 16512902.
  9. 9.0 9.1 9.2 9.3 9.4 9.5 9.6 9.7 "Public Health Image Library (PHIL)".

References


da:Bacillus cereus de:Bacillus cereus nl:Bacillus cereus sv:Bacillus cereus


Template:WikiDoc Sources